The number of Americans getting COVID shots is down 24% this year, driving the vaccine maker’s share price to its lowest level since before the pandemic.
In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...
The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now have to live with.
11monon MSNOpinion
Vaccine skeptics like Trump nominees Kennedy, Weldon are threat to public health | Opinion
A common thread among Donald Trump's nominees like RFK Jr. is a hyper focus on potential vaccine side effects as opposed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback